+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Progesterone Receptor Modulator Market - Global Forecast 2026-2032- Product Image
Progesterone Receptor Modulator Market - Global Forecast 2026-2032- Product Image
New

Progesterone Receptor Modulator Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124790
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Progesterone Receptor Modulator Market is experiencing rapid evolution as advancements in reproductive health and oncology demand greater precision. Senior decision-makers face new challenges in harmonizing innovation, stringent regulation, and consistent supply within a dynamic clinical environment.

Market Snapshot: Progesterone Receptor Modulator Market

According to recent research, the Progesterone Receptor Modulator Market expanded from USD 565.27 million in 2025 to USD 616.08 million in 2026. The sector is projected to maintain a CAGR of 9.69%, reaching USD 1.08 billion by 2032. Growth reflects rising demand for targeted hormone pathway management, broadening clinical applications, and a heightened focus on delivering measurable patient outcomes in global healthcare markets. Senior leaders are seeking differentiated strategies to address expanding opportunities and emerging regulatory challenges.

Scope & Segmentation

  • Indication Segments: The market covers therapeutic areas such as uterine fibroids, endometriosis, reproductive health (with applications extending to contraception-adjacent uses), and oncology-related therapies.
  • Product Types: Offerings include both selective progesterone receptor modulators and progesterone receptor antagonists, each delivering distinct efficacy and safety profiles across indications.
  • Administration Routes: Available forms encompass oral, long-acting, and localized delivery, with each modality influencing patient adherence and clinical uptake.
  • Distribution Channels: Products reach patients through hospital pharmacy, retail pharmacy, and e-pharmacy models, each presenting unique requirements for infrastructure, patient education, and support.
  • Regional Coverage: The market landscape spans the Americas, Europe, Middle East, Africa, and Asia-Pacific, with each region demonstrating unique access enablers, regulatory frameworks, and adoption dynamics that influence market penetration strategies.
  • Technology Trends: Progress includes molecule selectivity enhancements, tissue-specific targeting, integration of digital prescribing tools, and the emergence of electronic clinical decision support systems to optimize patient care and monitor use in real time.

Key Takeaways

  • Developers are moving from broad-spectrum antagonists to finely tuned modulators, enabling improved safety, tailored patient outcomes, and support for specific clinical needs.
  • Robust long-term safety data, particularly concerning endometrial and hepatic profiles, is now central to product differentiation and stakeholder trust across markets.
  • Indication-driven adoption trends highlight tolerability and sustained adherence as priorities in fibroid management, while reversibility and quality-of-life enhancements shape preferences in reproductive health applications.
  • Expansion of telehealth and connected digital solutions is transforming care delivery; manufacturers increasingly need to enable remote prescribing, education, and ongoing patient monitoring, adapting to evolving provider workflows.
  • Strategic advantage increasingly depends on integrating clinical validation, adaptable supply operations, and collaborative product launch strategies to achieve commercial resilience.
  • Supply resilience is now a key focus area, as regulatory and trade complexity require strong manufacturing controls and proactive risk mitigation to ensure consistent availability.

Tariff Impact on PRM Supply Chains

Forthcoming U.S. tariffs in 2025 are introducing additional challenges for progesterone receptor modulator supply chains. The greatest impact is seen in upstream procurement, specifically within sourcing of raw materials and intermediates. Companies are responding by implementing dual sourcing, authorizing alternative suppliers, and reinforcing supply chain flexibility. Adjustments to suppliers or contract manufacturers necessitate complete regulatory comparability evaluations, which can influence commercialization timelines. Early, integrated planning across operational and compliance units is essential to maintain regulatory alignment and product availability.

Methodology & Data Sources

This report consolidates findings from primary and secondary research to create a comprehensive market overview. Secondary sources include recent clinical trial results, regulatory documentation, industry briefings, and healthcare policy materials. In addition, structured interviews with domain experts—spanning clinicians, pharmacists, and manufacturing leaders—highlight real-world practice changes and operational considerations in supply, distribution, and ongoing product surveillance.

Why This Report Matters

  • Empowers R&D, commercial, and market access executives to adapt segmentation, clinical evidence, and regional compliance strategies to evolving market conditions.
  • Provides procurement and manufacturing leaders with actionable insights to bolster supply chain robustness, minimize exposure to trade disruptions, and manage risk.
  • Equips medical affairs and commercial teams with granular guidance for differentiation by indication and recalibrating distribution and channel tactics across varied regulatory contexts.

Conclusion

Future market leadership in progesterone receptor modulators will favor companies aligning targeted science, operational flexibility, and practical monitoring. Integrative strategies across development, supply chain management, and market access will be fundamental for sustained industry presence.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Progesterone Receptor Modulator Market, by Indication
8.1. Breast Cancer
8.2. Endometriosis
8.3. Fertility Treatment
8.4. Uterine Fibroids
9. Progesterone Receptor Modulator Market, by Product Type
9.1. Agonists
9.2. Antagonists
9.3. Selective Modulators
10. Progesterone Receptor Modulator Market, by Dosage Form
10.1. Capsules
10.1.1. Hard Capsules
10.1.2. Soft Gelatin
10.2. Injectables
10.2.1. Intramuscular
10.2.2. Intravenous
10.3. Oral Tablets
10.3.1. Extended Release
10.3.2. Immediate Release
10.4. Topical Gels
11. Progesterone Receptor Modulator Market, by Route Of Administration
11.1. Oral
11.2. Parenteral
11.3. Topical
12. Progesterone Receptor Modulator Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.2.1. Business To Business
12.2.2. Business To Consumer
12.3. Retail Pharmacy
13. Progesterone Receptor Modulator Market, by End User
13.1. Home Care Settings
13.2. Hospitals
13.2.1. Government Hospitals
13.2.2. Private Hospitals
13.3. Specialty Clinics
14. Progesterone Receptor Modulator Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Progesterone Receptor Modulator Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Progesterone Receptor Modulator Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Progesterone Receptor Modulator Market
18. China Progesterone Receptor Modulator Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Bayer AG
19.7. Cadila Healthcare Limited
19.8. Cipla Limited
19.9. Ferring Pharmaceuticals A/S
19.10. Gedeon Richter Plc.
19.11. HRA Pharma SAS
19.12. Ligand Pharmaceuticals Incorporated
19.13. Lupin Limited
19.14. Merck & Co., Inc.
19.15. Organon & Co.
19.16. Pfizer Inc.
19.17. PregLem SA
19.18. Sun Pharmaceutical Industries Limited
19.19. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ENDOMETRIOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ENDOMETRIOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY FERTILITY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY FERTILITY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY FERTILITY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SELECTIVE MODULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SELECTIVE MODULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SELECTIVE MODULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HARD CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HARD CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SOFT GELATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SOFT GELATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SOFT GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO BUSINESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO BUSINESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 156. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 157. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 158. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 180. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 181. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 182. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 186. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 203. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 205. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 207. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 208. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 209. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. ASEAN PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 215. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 217. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 218. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 219. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 220. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 221. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 223. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. GCC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 237. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 239. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 241. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 242. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 243. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 244. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 245. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 247. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. BRICS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 251. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 253. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 254. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 255. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 256. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 257. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 259. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. G7 PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 261. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 263. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 264. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 265. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 266. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 267. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 268. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 269. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 271. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. NATO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 286. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 288. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 289. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 290. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
TABLE 291. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2032 (USD MILLION)
TABLE 292. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2032 (USD MILLION)
TABLE 293. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 294. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 295. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 296. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. CHINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Progesterone Receptor Modulator market report include:
  • AbbVie Inc.
  • Bayer AG
  • Cadila Healthcare Limited
  • Cipla Limited
  • Ferring Pharmaceuticals A/S
  • Gedeon Richter Plc.
  • HRA Pharma SAS
  • Ligand Pharmaceuticals Incorporated
  • Lupin Limited
  • Merck & Co., Inc.
  • Organon & Co.
  • Pfizer Inc.
  • PregLem SA
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 616.08 Million
Forecasted Market Value ( USD ) by 2032 $ 1080 Million
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Progesterone Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Progesterone Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 86 Pages
  • Global
From
Progesterone Receptor Agonist - Pipeline Insight, 2025 - Product Image

Progesterone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • 90 Pages
  • Global
From
Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2025 - Product Image

Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Progesterone Market - Global Forecast 2026-2032 - Product Image

Progesterone Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Progesterone Global Market Report 2025 - Product Image

Progesterone Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.